EDIT
Editas Medicine·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Capital flows are surprisingly healthy with a 7.55/10 fund-flow score, showing net inflows across block, small, medium, and large sizes despite a negative overall trend. Analyst sentiment is split: one Strong Buy and one Neutral rating yield a weighted score of 1.26, classified as 'Netural' with market expectations leaning pessimistic. This blend of robust fund inflows and lukewarm analyst views adds complexity to the investment case.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-05
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for EDIT?
- EDIT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).
